Stopping RAS Inhibitors After AKI Ups Risk for Adverse Events
Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators.
Nephrology Conferences
MRA Treatment Ups Hyperkalemia Risk, but Not Death in CKD
Mineralocorticoid receptor antagonist treatment is often not recommended in patients with advanced kidney disease due to perceived risk of hyperkalemia and death, investigators noted.
SGLT2 Inhibitors Safe for KTRs, Data Show
The safety profile of SGLT2 inhibitors in kidney transplant recipients with type 2 diabetes is similar to that of other patient populations, new research suggests.
Older Living Donor Kidneys Associated With Worse Outcomes
How outcomes differ between recipients of deceased vs living donor kidneys of advanced age needs to be studied further.
Valacyclovir vs Valganciclovir for CMV Prophylaxis in KTRs
Although valganciclovir is an effective CMV prophylactic agent after kidney transplantation, it is associated with significant side effects.
Membranous Nephropathy Often Recurs After Kidney Transplantation
Effective therapy of post-transplant membranous nephropathy may improve outcomes.
Kidney Transplant Survival Benefit Greater for Patients on Dialysis
The current US Kidney Allocation System (KAS) may disadvantage waitlist candidates already receiving dialysis, according to investigators.
Kidney Transplant Outcomes Similar Regardless of Donor HCV Status
In a study, aviremic recipients of HCV-positive and HCV-negative deceased donor kidneys had similar 12-month transplant outcomes.
Delayed Graft Function More Likely With AKI Donor Kidneys
A growing body of research supports harvesting and transplanting of donor acute kidney injury kidneys.
Diabetes in Kidney Transplant Recipients Ups Risk for Overall Graft Loss
The increased death risk associated with type 2 diabetes in kidney transplant recipients does not vary significantly by body mass index, according to investigators.
- Loading...
Loading...
Next post in American Transplant Congress
Loading... 
Loading...